Skye Bioscience, Inc. (($SKYE)) has held its Q2 earnings call. Read on for the main highlights of the call. Skye Bioscience’s recent earnings call ...

Detailed price information for Skye Bioscience Inc (SKYE-Q) from The Globe and Mail including charting and trades.

Skye Bioscience Inc (SKYE) reports significant advancements in clinical trials and financial stability, despite increased ...

Q2 2025 Management View Punit S. Dhillon, President and CEO, highlighted the imminent reporting of Phase IIa data for ...

Reiterate top-line data readout from CBeyond™ Phase 2a study of nimacimab planned late Q3/early Q4 2025Patient enrollment in ...

View the latest Skye Bioscience Inc. (SKYE) stock price, news, historical charts, analyst ratings and financial information from WSJ.

SAN DIEGO, July 30, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on advancing new therapeutic pathways for obesity and other ...

Skye Bioscience to Announce Second Quarter 2025 Financial Results and Business Update on August 7, 2025SAN DIEGO, July 30, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a ...

Skye Bioscience to Announce Second Quarter 2025 Financial Results and Business Update on August 7, 2025Disclaimer The content, including but not limited to any articles, news, quotes, information, ...

SAN DIEGO, July 30, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on advancing new therapeutic pathways for obesity and ...